MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 530279 | Name: Ritrosulfan

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Ritrosulfan is an Antineoplastic Agent.

Chemical Structure

Ritrosulfan
Ritrosulfan
CAS#4148-16-7

Theoretical Analysis

MedKoo Cat#: 530279

Name: Ritrosulfan

CAS#: 4148-16-7

Chemical Formula: C10H22N2O10S22-

Exact Mass: 394.0727

Molecular Weight: 394.41

Elemental Analysis: C, 30.45; H, 5.62; N, 7.10; O, 40.56; S, 16.26

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Ritrosulfan
IUPAC/Chemical Name
1,4-Dideoxy-1,4-bis((2-hydroxyethyl)amino)erythritol 1,4-dimethanesulfonate (ester)
InChi Key
FLKYKLXEGVMXSW-OXYCZDQYSA-L
InChi Code
InChI=1S/C10H24N2O10S2/c13-3-1-11-7(5-23(17,18)19)9(15)10(16)8(12-2-4-14)6-24(20,21)22/h7-16H,1-6H2,(H,17,18,19)(H,20,21,22)/p-2/t7?,8?,9-,10+
SMILES Code
O[C@H]([C@@H](C(CS(=O)([O-])=O)NCCO)O)C(CS(=O)([O-])=O)NCCO
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 394.41 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Korda J, Genti G, Káli G, Bálint G, Bátory G. Successful treatment of respiratory failure associated with dermatomyositis. J Rheumatol. 1987 Oct;14(5):1075-6. PubMed PMID: 3323507. 2: Zárandy B, Szabó J, Molnár I, Sallai Z, Simon Z, Légrády J. [Recurrence prevention of papillomas of the bladder using lycurim instillation]. Z Urol Nephrol. 1984 Oct;77(10):599-603. German. PubMed PMID: 6549094. 3: Ban J. [Lycurim in combined chemotherapy in vitro]. Lijec Vjesn. 1984 Sep;106(9):374-8. Croatian. PubMed PMID: 6548786. 4: Kliuchanskaia NV, Iliukhin AV, Kiselev AV. [Evaluation of the therapeutic effectiveness of likurim in lymphosarcoma in dogs]. Gematol Transfuziol. 1984 Aug;29(8):46-9. Russian. PubMed PMID: 6548198. 5: Klener P. [Lycurim, lymphomas and cytostatic trials]. Vnitr Lek. 1984 Jul;30(7):714-6. Czech. PubMed PMID: 6388153. 6: Hegedüs L, Kerpel-Fronius S, Horváth IP, Hindy I, Eckhardt S. A sensitive assay for the pharmacokinetic investigation of a rapidly hydrolyzing alkylating agent Lycurim (ritrosulfan; R-74; NSC-122 402). Eur J Cancer Clin Oncol. 1984 Jul;20(7):933-8. PubMed PMID: 6086356. 7: Pál K, Kopper L, Lapis K. Chemotherapeutic sensitivity of liver metastases from intrasplenically-growing Lewis lung tumor. Clin Exp Metastasis. 1983 Oct-Dec;1(4):341-7. PubMed PMID: 6443744. 8: Kondás J, Szentgyörgyi E. Recurrency rate influencing effect on intravesical Lycurim treatment in transurethrally resected bladder tumours. Ther Hung. 1983;31(2):55-8. PubMed PMID: 6571182. 9: Lui MS, Jackson RC, Harkrader RJ, Weber G. Rat hepatomas: chemotherapy with lycurim and pyrazofurin. J Natl Cancer Inst. 1982 Apr;68(4):665-8. PubMed PMID: 6951080. 10: Ban J, Olah E, Werber G. Action of lycurim and pyrazofurin on hepatoma 3924A cells in culture. Cancer Treat Rep. 1982 Feb;66(2):343-9. PubMed PMID: 6895716. 11: Klener P. Lycurim (NSC 122402) in the treatment of chronic lymphocytic leukemia. Neoplasma. 1982;29(1):87-92. PubMed PMID: 6896084. 12: Kerpel-Fronius S. Hungarian anticancer drugs (antineoplastics). Ther Hung. 1982;30(3):110-21. Review. PubMed PMID: 6095482. 13: Vygovskaya YI, Loginsky VE, Vorobel AV, Kondratieva NA, Mazurok AA, Korotky VV, Kotsay BR. Lycurim (R-74) in the therapy of chronic lymphocytic leukaemia. Haematologia (Budap). 1981 Dec;14(4):399-405. PubMed PMID: 6178656. 14: Kotlarek-Haus S, Frydecka I, Gatazka Z, Gabryś K. Evaluation of the therapeutic effect of lycurim in lymphoma. Ther Hung. 1981;29(3):124-7. PubMed PMID: 6897914. 15: Janicki K, Skotnicki AS, Blicharski J, Kwiatkowski A, Sliwczyńska-Dura B, Lisiewicz J. [Lycurim in the treatment of patients with chronic lymphocytic leukemia (author's transl)]. Przegl Lek. 1980;37(4):429-35. Polish. PubMed PMID: 6996043. 16: Kerpel-Fronius S, Csetényi J, Hegedüs L, Horváth IP, Ringwald G, Töttössy B, Eckhardt S. Chemical reactivity and intracavitary application of alkylating sugar alcohol derivatives. Oncology. 1980;37 Suppl 1:109-14. PubMed PMID: 6893858. 17: Stoychkov JN, Milushev AS, Todorov DK. Combined therapy of L1210 leukemia with cyclophosphamide and lycurim. Neoplasma. 1980;27(1):33-6. PubMed PMID: 6892839.